What RAD140 discussions on Reddit and YouTube describe
RAD140 is an experimental drug acting at the androgen receptor, and RAD-140 Reddit and YouTube accounts describe it as markedly increasing strength, just as often as causing hormone suppression and other adverse effects, and the products sold under its name as apparently counterfeit more often than not.
The published record is narrower. The only human trial of RAD140 enrolled women with advanced breast cancer and recorded raised liver tests at 10 mg twice daily; case reports, each a single patient, record drug-induced liver injury in men exposed to products sold as RAD140, and two further cases describe possible myocarditis, inflammation of cardiac muscle, and atraumatic splenic rupture, a torn spleen without preceding injury. Single cases, like anonymous accounts, show what can happen and not how often.
[Figure 1. RAD140’s published human record, 2022–2026. Every publication on people exposed to RAD140 among this article’s sources: one conference abstract of a phase 1/2 trial in women with advanced breast cancer, and four case reports, each describing one man exposed to a product sold as RAD140.]
Vosilasarm (EP0062) is the name under which RAD140, a selective androgen receptor modulator (SARM), reached that one trial, on the back of the laboratory and animal studies that supply much of what is known of the RAD 140 mechanism of action. Everything else said about the compound is, almost without exception, a single anonymous account. This article therefore sets those accounts against the trial and the published cases, and against what a regulator’s product testing and the anti-doping literature add, and leaves the UK legal position aside.
Is testolone the same as testosterone?
Testolone is simply RAD140, a selective androgen receptor modulator, and not testosterone, the principal androgen produced in the testes. The two share the androgen receptor, and SARMs were developed as potential alternatives to testosterone supplementation in hypogonadism, a failure of the testes to produce enough of the hormone; the resemblance ends at the receptor, since RAD140 is a synthetic non-steroidal compound and the hormone itself an endogenous steroid.
The anti-doping literature characterises SARMs as anabolic, building skeletal muscle and bone, with markedly reduced androgenic effects, the masculinising actions on tissues such as skin and hair. Anabolic-androgenic steroids (the synthetic derivatives of testosterone) carry both properties together, and the SARM class was designed to separate the anabolic action from the androgenic one. That claimed separation is the premise of the class, so it is what the RAD140 vs testosterone comparison tests, on hormone suppression and against prescribed testosterone treatment.
Does RAD140 lower testosterone, and by how much?
RAD140 is widely understood to lower the body’s own testosterone production, and that fall is what the accounts call hormone suppression; its size is generally left without a figure and described in kind, as partial suppression visible on a blood panel rather than the near-complete shutdown attributed to injectable androgens. The mechanism offered is feedback. RAD140 occupies the androgen receptor, which also carries testosterone’s own signal, so the circuit governing testosterone output reads it as sufficient androgen and reduces production.
One study in women with breast cancer
The one human trial among this article’s sources is a phase 1/2 trial of vosilasarm, an early RAD 140 study of tolerated dose and first activity in women with advanced or metastatic AR-positive, ER-positive, HER2-negative breast cancer, tumours whose cells carry androgen and oestrogen receptors but not extra amounts of the growth protein HER2. The investigators recorded raised liver tests at 10 mg twice daily. Two limits attach to that result: it is reported in a conference abstract rather than a full paper, so the detail behind it is thin, and the participants were women with advanced cancer under oncological care, not the healthy men of the descriptions outside the trial record.
Does RAD140 shrink the prostate?
RAD140 is not widely held to shrink an untreated prostate; the gland is generally held to respond less to RAD140 than to testosterone, and that weaker response is the tissue selectivity from which the SARM class takes its name. A weaker response and shrinkage are different claims. RAD140 is commonly described as leaving the gland much as it is, and preclinical accounts describe less growth there than an equivalent exposure to androgen would produce.
Is RAD140 bad for the liver?
It has been linked to cholestatic drug-induced liver injury in published cases of young men, the trial recorded raised liver tests and LiverTox lists the class, a record set out in full under RAD-140 liver toxicity.
The trial’s RAD140 dose was the one at which raised liver tests appeared, the published cases date the injury to weeks or months of exposure rather than to an amount, and both cases resolved once exposure ended.
What do blood tests show for users on a cycle?
Accounts outside the published studies describe low testosterone values after exposure ended as a fairly frequent finding, alongside concern over cholesterol and over liver tests, yet the same accounts describe blood values as rarely measured at all, and exposures of several weeks appear in them with no test before, during or after. That gap is why a baseline blood test, drawn before any exposure begins, is widely urged as the start of RAD 140 blood work, with a repeat afterwards.
In one of those accounts, blood values are back to normal a year later. The values themselves are almost never set down, so these descriptions give a direction and not a measurement.
Heart and spleen emergencies in published case reports
Two published cases describe emergencies outside liver tissue. The first concerns RAD-140 and the heart: the report is of a young man with possible acute myocarditis after exposure to RAD-140, and it claims nothing beyond that one case.
The second describes atraumatic splenic rupture in a 54-year-old man exposed to RAD-140 and to MK-677 (ibutamoren), a growth hormone secretagogue. Rupture of that kind is rare, life-threatening and mostly confined to spleens already diseased, which is why the histology carried weight: large areas of splenic infarction in the removed tissue, with features raising the possibility of an underlying vascular malformation.
The authors mention the two compounds because of the parallel with anabolic-androgenic steroids and peliosis, a condition of blood-filled vascular cavities that predispose an organ to rupture. On that reasoning they raise androgen receptor signalling and the insulin-like growth factor 1 (IGF-1) pathway as possible contributors rather than as causes, and call the role of the SARM RAD140 and of MK-677 speculative. Clinicians first controlled the bleeding by splenic artery embolization, blocking the vessel that feeds the spleen, and when the effect held only transiently they controlled it by total splenectomy, the removal of the whole spleen.
Strength and muscle changes described in discussions
Strength is described, outside the trial record, as the change that appears first and most often, with large increases in the loads lifted within the first few weeks of exposure, and the muscle mass added alongside it as dry, a word for little water retention and visible outlines. That dryness is the standing contrast drawn with LGD-4033 (ligandrol), another selective androgen receptor modulator, which is linked instead with greater body weight and more water retention.
In descriptions beyond the trials, a good part of the added strength fades once exposure has ended, and a smaller number of accounts describe little effect at all and question whether the added mass was muscle tissue rather than water and fat. Such doubt is hard to settle, because much of the RAD 140 experience set out in these accounts describes a planned first exposure rather than a recorded outcome.
What are the pros and cons of RAD 140?
Outside the published trials, the RAD 140 pros and cons are described as falling into two columns:
On the one side:
greater muscle strength
a dry increase in lean body mass
On the other:
hormone suppression
acne
hair shedding
a product of unverified content
Outside the published trials, lean body mass in the first column means the body mass that is not fat. The second column holds two signs of androgen excess, acne and hair shedding in the male pattern, beside the suppression and the product itself. Of everything in the two columns, only the product of unverified content has anything in the published record answering to it.
How soon effects are described, and when nothing is felt
The onset of effects is described, outside the trial record, as varying from the first day of exposure to no perceptible onset: greater stamina in the first week, a sense of fullness in muscle tissue hours after a first low dose, which the same account questions as a placebo effect, and no less often a full fortnight in which nothing is felt, an absence attributed at once to the product rather than to individual physiology. The cause of that absence is argued both ways, a slow onset that a further week or two would reveal against a suspicion about the contents of the container.
Sweating, headaches, joints and other complaints described in discussions
Among the effects described outside the trials the minor complaints run in this order of frequency:
a sensation of warmth and heavy sweating
headaches
joint aches
acne with oily skin
hair shedding
nausea, dizziness and fatigue
raised blood pressure
Warmth and heavy sweating are the most frequent, with headaches close behind; joint aches arrive during exposure rather than after it, and acne with oily skin often enough to be treated as expected. Hair shedding is described, outside the trial record, as a complaint decisive enough that a number of accounts favour LGD-4033 for that reason alone, nausea, dizziness and fatigue appear in an account of a first exposure in a woman, arriving before any change in strength, and raised blood pressure recurs as a worry rather than as a measured value.
Does RAD140 affect sleep, mood and libido?
RAD140 is described, outside the published studies, as affecting all three of sleep, mood and libido during exposure. Sleep is the one of the three with a named disturbance, insomnia being the complaint most often attributed to RAD140; mood shifts early, with raised confidence and drive and sometimes a shorter temper; libido follows a different course, rising during exposure and falling away once exposure ends, in step with the hormone suppression those accounts describe.
What do YouTube reviewers say about RAD140?
RAD140 is presented, in accounts outside the published studies, as a compound with claimed benefits, a course of effects over successive weeks of exposure and a set of side effects, and a typical RAD 140 SARM review sets out the three in that order. The same accounts describe RAD-150 (a related compound) as a newer form of RAD140, and the RAD 140 vs RAD 150 comparison is the one most often drawn. None of that material is a study, and it is described as clear rather than as checked against anything.
[Figure 2. RAD140 (Testolone) – A Comprehensive Overview. A YouTube review of RAD140’s preclinical data, including how it compared with testosterone in the muscle and prostate tissue of rats.]
What do older users, such as those over 40, report?
Older men, such as those over 40, are assigned no effect peculiar to RAD140 among those described outside the trials, and what such descriptions add for that age group is a later start to exposure rather than any effect of later life; in those men the compound is weighed against prescribed testosterone treatment, and the question raised is which baseline values were measured before any exposure began.
What is known about RAD140 in teenagers?
In descriptions beyond the trials, the risk of RAD 140 in teenagers is widely understood to be greater than in adults, because the hypothalamic-pituitary-gonadal axis, the hormone circuit linking the brain with the testes or ovaries, is still maturing before adulthood, and suppression of that circuit is held to matter more while it is still being established. Bone growth gives a second reason, androgenic compounds being described as acting on the growth plates that close at the end of puberty, so the age at which exposure begins is held to change the kind of risk, not only its size.
How discussions compare and combine RAD140 with LGD-4033, ostarine and MK-677
RAD140 is compared most clearly with LGD-4033 (ligandrol) in the effects described outside the trials: more body weight and more water retention with ligandrol, drier strength with RAD140, and much the same increase in muscle mass with either. A comparison of that kind depends on knowing what is in each container; the LGD-4033 for sale in the shop, supplied for laboratory research, comes with batch and purity data.
Beside both stands ostarine (MK-2866, enobosarm), a selective androgen receptor modulator developed against muscle wasting; it is described, outside the trial record, as the mildest of the three and the least suppressive, and the shop stocks ostarine MK-2866 for laboratory research and the same side-by-side work. Two further reference points flank RAD140 in these descriptions: Anavar (oxandrolone, an orally active anabolic-androgenic steroid) and prescribed testosterone.
Accounts outside the published studies describe heavy sweating, changes in sleep, water retention and joint aches arriving together when RAD140 is combined with ibutamoren MK-677, which the shop also supplies, and the combination of RAD140 with LGD-4033 is occasionally described as more suppressive than either alone, on the reasoning that two androgen receptor ligands suppress more than one does.
Shutdown, recovery and strength after stopping, in discussions
The weeks after exposure ended are described, outside the published trials, as a period of low drive and low energy, both attributed to hormone suppression, and part of the increase in strength during exposure as lost over those same weeks. Other compounds are sometimes administered in that period, among them enclomiphene, a selective oestrogen receptor modulator (SERM) that raises the body’s own testosterone production. A return to normal well-being at a later stage is described in several accounts, while long-standing concern over RAD 140 suppression and recovery persists in others, and the degree of suppression from RAD140 relative to ostarine and LGD-4033 is argued both ways, with nothing in such descriptions to settle the comparison.
How do users tell if their RAD140 is fake or underdosed?
Beyond the trial data, fake or under-dosed RAD140 is described as told apart from genuine product by one test only, whether any effect at all appears after several weeks of daily administration, and a product that fails that test is termed ‘bunk’; a change to a product from another source is described, fairly often, as followed at once by a noticeable difference. The only reliable mark of legit RAD 140 is nonetheless widely held to be not such impressions but an independent certificate of analysis stating the measured content of a batch, and a few accounts go further and describe the absence of any effect as proving nothing about the content of the container.
A regulator that tested unapproved SARM products found them significantly under-dosed, which gives the absence of any felt effect in those accounts a cause in the product, and is why the shop’s RAD-140 for sale comes with batch and purity data.
In those accounts the same is asked of every compound, and the shop’s UK SARMs range carries the same batch and purity data.
Will RAD140 fail a drug test?
Yes, where the panel covers SARMs, which WADA prohibits at all times and accredited laboratories identify by mass spectrometry; the methods and detection windows are set out under RAD 140 drug test.
How long does RAD140 stay in the system?
RAD140 can be detected in urine for several weeks after exposure, a detection window shared by most SARMs. Further evidence after an adverse analytical finding can come from hair or nail testing, though a negative hair or nail result cannot exclude exposure to the detected compound and cannot overrule the original result; and because a violation is usually known only weeks after collection, the sample itself is seldom still available for that further testing.
What anonymous accounts and single cases cannot show
Neither anonymous accounts nor single cases carry a denominator, so neither can show how often any of these outcomes occurs. The trial result is a conference abstract on women with advanced cancer, not a full paper on healthy men; possible myocarditis and atraumatic splenic rupture each appear once among the published cases, and in the splenic case the authors themselves call the role of the compounds speculative. The RAD-140 Reddit accounts and the other online descriptions are unverified, so the product behind each is unknown, and no effect can be assigned to RAD140 alone, because the urine screening of the Swedish samples shows exposure to more than one compound at a time to be usual.
What each kind of evidence can show
Evidence
What it is
What it reports
What it cannot show
Vosilasarm phase 1/2 trial
Conference abstract; women with advanced AR+/ER+/HER2− breast cancer
Raised liver tests at 10 mg twice daily
Effects in healthy men; full detail, since there is no full paper
Case reports
Single patients
Liver injury, possible myocarditis, splenic rupture
How often any outcome occurs; in the splenic case, cause
LiverTox monograph
US drug-induced liver injury database, class entry
Frequency, product content, or effect of RAD-140 alone
Several effects in this article are known only from descriptions outside the published trials: changes in strength and muscle mass, time to onset, sweating, headaches, joint aches, acne, oily skin, hair shedding, nausea, dizziness, the blood values described outside the trials and the signs read as marking a fake product. No published study among this article’s sources has measured any of them.
Important information. This article summarises published research and case reports, and notes where effects are described outside the published trials. It is not medical advice, and Max Muscle Labs does not give dosing guidance or any information implying human use. Many of the compounds discussed here are not approved for human use by the MHRA, the FDA or any other regulator, and many are prohibited in sport by WADA. Products sold by Max Muscle Labs are supplied strictly for laboratory and analytical research use and are not for human or veterinary consumption.
Check what you remember
4 questions on this article; the right answer is marked.
Who were the participants in the only human trial of RAD140, run under the name vosilasarm?
Women with advanced breast cancer ✓
Healthy young men in strength training
Older men with low testosterone
Adults with muscle-wasting illness
The one human trial enrolled women with advanced AR-positive, ER-positive, HER2-negative breast cancer, and it is reported only as a conference abstract.
What happened to the jaundice in the two published liver-injury cases once the product was stopped?
It improved in both men over months ✓
It cleared within days in both men
It improved in one man, not the other
It persisted despite stopping the product
Both men recovered after the product was withdrawn; in the 22-year-old, liver enzymes returned to normal three to 12 months later.
What did Australia's medicines regulator find when it tested unapproved SARM products?
Products significantly under-dosed ✓
Contents closely matching the labels
Products containing more than stated
Steroids in place of SARMs
The TGA found unapproved SARM products significantly under-dosed, which offers one explanation, in the product rather than the compound, for accounts of feeling nothing.
In Swedish healthcare urine samples screened with anti-doping methods, what did the SARM-positive samples commonly show?
Two or more SARMs in most of them ✓
RAD140 alone in almost every sample
Ostarine as the only SARM found
Positives mostly in female samples
More than half of the SARM-positive samples contained two or more SARMs, so no reported effect can be assigned to RAD140 alone.
Specialty Registrar in Endocrinology and Diabetes; Clinical Research Fellow
Elizabeth Hyams is a specialty registrar in endocrinology and diabetes and a clinical research fellow in the Reproductive Endocrinology group at Imperial College London. Elizabeth specialises in endocrinology and the hypothalamic-pituitary-gonadal axis.
ostarine for cutting is untested in lean adults, but in a semaglutide weight-loss trial enobosarm cut lean-mass loss by 71% and raised fat loss by 27%.
MK-677 Reddit accounts describe increased appetite and deeper sleep early on, while trials recorded more fat-free mass and IGF-1 but no rise in strength.
What does RAD-140 do to the brain is known only from nerve-cell and rat studies, where it shielded neurons from injury about as well as testosterone did.
The first RAD 140 study tested the compound in 22 postmenopausal women with metastatic breast cancer, setting 100 mg daily as the highest tolerated dose.
Hurry while stocks last! Use code PAYDAY15 at checkout to get 15% off sitewide. Valid for
Join the WaitlistWe will inform you when the product is back in stock. Enter your email address below.
RAD-140 Reddit: discussions set against the studies
By Ailsa Gemmell · Reviewed by Elizabeth Hyams
Published · Updated · 16 min read
What RAD140 discussions on Reddit and YouTube describe
RAD140 is an experimental drug acting at the androgen receptor, and RAD-140 Reddit and YouTube accounts describe it as markedly increasing strength, just as often as causing hormone suppression and other adverse effects, and the products sold under its name as apparently counterfeit more often than not.
The published record is narrower. The only human trial of RAD140 enrolled women with advanced breast cancer and recorded raised liver tests at 10 mg twice daily; case reports, each a single patient, record drug-induced liver injury in men exposed to products sold as RAD140, and two further cases describe possible myocarditis, inflammation of cardiac muscle, and atraumatic splenic rupture, a torn spleen without preceding injury. Single cases, like anonymous accounts, show what can happen and not how often.
Vosilasarm (EP0062) is the name under which RAD140, a selective androgen receptor modulator (SARM), reached that one trial, on the back of the laboratory and animal studies that supply much of what is known of the RAD 140 mechanism of action. Everything else said about the compound is, almost without exception, a single anonymous account. This article therefore sets those accounts against the trial and the published cases, and against what a regulator’s product testing and the anti-doping literature add, and leaves the UK legal position aside.
Is testolone the same as testosterone?
Testolone is simply RAD140, a selective androgen receptor modulator, and not testosterone, the principal androgen produced in the testes. The two share the androgen receptor, and SARMs were developed as potential alternatives to testosterone supplementation in hypogonadism, a failure of the testes to produce enough of the hormone; the resemblance ends at the receptor, since RAD140 is a synthetic non-steroidal compound and the hormone itself an endogenous steroid.
The anti-doping literature characterises SARMs as anabolic, building skeletal muscle and bone, with markedly reduced androgenic effects, the masculinising actions on tissues such as skin and hair. Anabolic-androgenic steroids (the synthetic derivatives of testosterone) carry both properties together, and the SARM class was designed to separate the anabolic action from the androgenic one. That claimed separation is the premise of the class, so it is what the RAD140 vs testosterone comparison tests, on hormone suppression and against prescribed testosterone treatment.
Does RAD140 lower testosterone, and by how much?
RAD140 is widely understood to lower the body’s own testosterone production, and that fall is what the accounts call hormone suppression; its size is generally left without a figure and described in kind, as partial suppression visible on a blood panel rather than the near-complete shutdown attributed to injectable androgens. The mechanism offered is feedback. RAD140 occupies the androgen receptor, which also carries testosterone’s own signal, so the circuit governing testosterone output reads it as sufficient androgen and reduces production.
One study in women with breast cancer
The one human trial among this article’s sources is a phase 1/2 trial of vosilasarm, an early RAD 140 study of tolerated dose and first activity in women with advanced or metastatic AR-positive, ER-positive, HER2-negative breast cancer, tumours whose cells carry androgen and oestrogen receptors but not extra amounts of the growth protein HER2. The investigators recorded raised liver tests at 10 mg twice daily. Two limits attach to that result: it is reported in a conference abstract rather than a full paper, so the detail behind it is thin, and the participants were women with advanced cancer under oncological care, not the healthy men of the descriptions outside the trial record.
Does RAD140 shrink the prostate?
RAD140 is not widely held to shrink an untreated prostate; the gland is generally held to respond less to RAD140 than to testosterone, and that weaker response is the tissue selectivity from which the SARM class takes its name. A weaker response and shrinkage are different claims. RAD140 is commonly described as leaving the gland much as it is, and preclinical accounts describe less growth there than an equivalent exposure to androgen would produce.
Is RAD140 bad for the liver?
It has been linked to cholestatic drug-induced liver injury in published cases of young men, the trial recorded raised liver tests and LiverTox lists the class, a record set out in full under RAD-140 liver toxicity.
The trial’s RAD140 dose was the one at which raised liver tests appeared, the published cases date the injury to weeks or months of exposure rather than to an amount, and both cases resolved once exposure ended.
What do blood tests show for users on a cycle?
Accounts outside the published studies describe low testosterone values after exposure ended as a fairly frequent finding, alongside concern over cholesterol and over liver tests, yet the same accounts describe blood values as rarely measured at all, and exposures of several weeks appear in them with no test before, during or after. That gap is why a baseline blood test, drawn before any exposure begins, is widely urged as the start of RAD 140 blood work, with a repeat afterwards.
In one of those accounts, blood values are back to normal a year later. The values themselves are almost never set down, so these descriptions give a direction and not a measurement.
Heart and spleen emergencies in published case reports
Two published cases describe emergencies outside liver tissue. The first concerns RAD-140 and the heart: the report is of a young man with possible acute myocarditis after exposure to RAD-140, and it claims nothing beyond that one case.
The second describes atraumatic splenic rupture in a 54-year-old man exposed to RAD-140 and to MK-677 (ibutamoren), a growth hormone secretagogue. Rupture of that kind is rare, life-threatening and mostly confined to spleens already diseased, which is why the histology carried weight: large areas of splenic infarction in the removed tissue, with features raising the possibility of an underlying vascular malformation.
The authors mention the two compounds because of the parallel with anabolic-androgenic steroids and peliosis, a condition of blood-filled vascular cavities that predispose an organ to rupture. On that reasoning they raise androgen receptor signalling and the insulin-like growth factor 1 (IGF-1) pathway as possible contributors rather than as causes, and call the role of the SARM RAD140 and of MK-677 speculative. Clinicians first controlled the bleeding by splenic artery embolization, blocking the vessel that feeds the spleen, and when the effect held only transiently they controlled it by total splenectomy, the removal of the whole spleen.
Strength and muscle changes described in discussions
Strength is described, outside the trial record, as the change that appears first and most often, with large increases in the loads lifted within the first few weeks of exposure, and the muscle mass added alongside it as dry, a word for little water retention and visible outlines. That dryness is the standing contrast drawn with LGD-4033 (ligandrol), another selective androgen receptor modulator, which is linked instead with greater body weight and more water retention.
In descriptions beyond the trials, a good part of the added strength fades once exposure has ended, and a smaller number of accounts describe little effect at all and question whether the added mass was muscle tissue rather than water and fat. Such doubt is hard to settle, because much of the RAD 140 experience set out in these accounts describes a planned first exposure rather than a recorded outcome.
What are the pros and cons of RAD 140?
Outside the published trials, the RAD 140 pros and cons are described as falling into two columns:
Outside the published trials, lean body mass in the first column means the body mass that is not fat. The second column holds two signs of androgen excess, acne and hair shedding in the male pattern, beside the suppression and the product itself. Of everything in the two columns, only the product of unverified content has anything in the published record answering to it.
How soon effects are described, and when nothing is felt
The onset of effects is described, outside the trial record, as varying from the first day of exposure to no perceptible onset: greater stamina in the first week, a sense of fullness in muscle tissue hours after a first low dose, which the same account questions as a placebo effect, and no less often a full fortnight in which nothing is felt, an absence attributed at once to the product rather than to individual physiology. The cause of that absence is argued both ways, a slow onset that a further week or two would reveal against a suspicion about the contents of the container.
Sweating, headaches, joints and other complaints described in discussions
Among the effects described outside the trials the minor complaints run in this order of frequency:
Warmth and heavy sweating are the most frequent, with headaches close behind; joint aches arrive during exposure rather than after it, and acne with oily skin often enough to be treated as expected. Hair shedding is described, outside the trial record, as a complaint decisive enough that a number of accounts favour LGD-4033 for that reason alone, nausea, dizziness and fatigue appear in an account of a first exposure in a woman, arriving before any change in strength, and raised blood pressure recurs as a worry rather than as a measured value.
Does RAD140 affect sleep, mood and libido?
RAD140 is described, outside the published studies, as affecting all three of sleep, mood and libido during exposure. Sleep is the one of the three with a named disturbance, insomnia being the complaint most often attributed to RAD140; mood shifts early, with raised confidence and drive and sometimes a shorter temper; libido follows a different course, rising during exposure and falling away once exposure ends, in step with the hormone suppression those accounts describe.
What do YouTube reviewers say about RAD140?
RAD140 is presented, in accounts outside the published studies, as a compound with claimed benefits, a course of effects over successive weeks of exposure and a set of side effects, and a typical RAD 140 SARM review sets out the three in that order. The same accounts describe RAD-150 (a related compound) as a newer form of RAD140, and the RAD 140 vs RAD 150 comparison is the one most often drawn. None of that material is a study, and it is described as clear rather than as checked against anything.
What do older users, such as those over 40, report?
Older men, such as those over 40, are assigned no effect peculiar to RAD140 among those described outside the trials, and what such descriptions add for that age group is a later start to exposure rather than any effect of later life; in those men the compound is weighed against prescribed testosterone treatment, and the question raised is which baseline values were measured before any exposure began.
What is known about RAD140 in teenagers?
In descriptions beyond the trials, the risk of RAD 140 in teenagers is widely understood to be greater than in adults, because the hypothalamic-pituitary-gonadal axis, the hormone circuit linking the brain with the testes or ovaries, is still maturing before adulthood, and suppression of that circuit is held to matter more while it is still being established. Bone growth gives a second reason, androgenic compounds being described as acting on the growth plates that close at the end of puberty, so the age at which exposure begins is held to change the kind of risk, not only its size.
How discussions compare and combine RAD140 with LGD-4033, ostarine and MK-677
RAD140 is compared most clearly with LGD-4033 (ligandrol) in the effects described outside the trials: more body weight and more water retention with ligandrol, drier strength with RAD140, and much the same increase in muscle mass with either. A comparison of that kind depends on knowing what is in each container; the LGD-4033 for sale in the shop, supplied for laboratory research, comes with batch and purity data.
Beside both stands ostarine (MK-2866, enobosarm), a selective androgen receptor modulator developed against muscle wasting; it is described, outside the trial record, as the mildest of the three and the least suppressive, and the shop stocks ostarine MK-2866 for laboratory research and the same side-by-side work. Two further reference points flank RAD140 in these descriptions: Anavar (oxandrolone, an orally active anabolic-androgenic steroid) and prescribed testosterone.
Accounts outside the published studies describe heavy sweating, changes in sleep, water retention and joint aches arriving together when RAD140 is combined with ibutamoren MK-677, which the shop also supplies, and the combination of RAD140 with LGD-4033 is occasionally described as more suppressive than either alone, on the reasoning that two androgen receptor ligands suppress more than one does.
Shutdown, recovery and strength after stopping, in discussions
The weeks after exposure ended are described, outside the published trials, as a period of low drive and low energy, both attributed to hormone suppression, and part of the increase in strength during exposure as lost over those same weeks. Other compounds are sometimes administered in that period, among them enclomiphene, a selective oestrogen receptor modulator (SERM) that raises the body’s own testosterone production. A return to normal well-being at a later stage is described in several accounts, while long-standing concern over RAD 140 suppression and recovery persists in others, and the degree of suppression from RAD140 relative to ostarine and LGD-4033 is argued both ways, with nothing in such descriptions to settle the comparison.
How do users tell if their RAD140 is fake or underdosed?
Beyond the trial data, fake or under-dosed RAD140 is described as told apart from genuine product by one test only, whether any effect at all appears after several weeks of daily administration, and a product that fails that test is termed ‘bunk’; a change to a product from another source is described, fairly often, as followed at once by a noticeable difference. The only reliable mark of legit RAD 140 is nonetheless widely held to be not such impressions but an independent certificate of analysis stating the measured content of a batch, and a few accounts go further and describe the absence of any effect as proving nothing about the content of the container.
A regulator that tested unapproved SARM products found them significantly under-dosed, which gives the absence of any felt effect in those accounts a cause in the product, and is why the shop’s RAD-140 for sale comes with batch and purity data.
In those accounts the same is asked of every compound, and the shop’s UK SARMs range carries the same batch and purity data.
Will RAD140 fail a drug test?
Yes, where the panel covers SARMs, which WADA prohibits at all times and accredited laboratories identify by mass spectrometry; the methods and detection windows are set out under RAD 140 drug test.
How long does RAD140 stay in the system?
RAD140 can be detected in urine for several weeks after exposure, a detection window shared by most SARMs. Further evidence after an adverse analytical finding can come from hair or nail testing, though a negative hair or nail result cannot exclude exposure to the detected compound and cannot overrule the original result; and because a violation is usually known only weeks after collection, the sample itself is seldom still available for that further testing.
What anonymous accounts and single cases cannot show
Neither anonymous accounts nor single cases carry a denominator, so neither can show how often any of these outcomes occurs. The trial result is a conference abstract on women with advanced cancer, not a full paper on healthy men; possible myocarditis and atraumatic splenic rupture each appear once among the published cases, and in the splenic case the authors themselves call the role of the compounds speculative. The RAD-140 Reddit accounts and the other online descriptions are unverified, so the product behind each is unknown, and no effect can be assigned to RAD140 alone, because the urine screening of the Swedish samples shows exposure to more than one compound at a time to be usual.
What each kind of evidence can show
Several effects in this article are known only from descriptions outside the published trials: changes in strength and muscle mass, time to onset, sweating, headaches, joint aches, acne, oily skin, hair shedding, nausea, dizziness, the blood values described outside the trials and the signs read as marking a fake product. No published study among this article’s sources has measured any of them.
Check what you remember
4 questions on this article; the right answer is marked.
The one human trial enrolled women with advanced AR-positive, ER-positive, HER2-negative breast cancer, and it is reported only as a conference abstract.
Both men recovered after the product was withdrawn; in the 22-year-old, liver enzymes returned to normal three to 12 months later.
The TGA found unapproved SARM products significantly under-dosed, which offers one explanation, in the product rather than the compound, for accounts of feeling nothing.
More than half of the SARM-positive samples contained two or more SARMs, so no reported effect can be assigned to RAD140 alone.
Ailsa Gemmell · NHS Greater Glasgow and Clyde
Specialty Registrar in Gastroenterology
Ailsa Gemmell is a specialty registrar in gastroenterology at NHS Greater Glasgow and Clyde. Ailsa specialises in hepatology and liver safety.
Elizabeth Hyams · Imperial College London · Last reviewed
Specialty Registrar in Endocrinology and Diabetes; Clinical Research Fellow
Elizabeth Hyams is a specialty registrar in endocrinology and diabetes and a clinical research fellow in the Reproductive Endocrinology group at Imperial College London. Elizabeth specialises in endocrinology and the hypothalamic-pituitary-gonadal axis.
Related Posts
Ostarine for cutting: lean mass and fat loss in the trials
ostarine for cutting is untested in lean adults, but in a semaglutide weight-loss trial enobosarm cut lean-mass loss by 71% and raised fat loss by 27%.
MK-677 Reddit: discussions weighed against the trials
MK-677 Reddit accounts describe increased appetite and deeper sleep early on, while trials recorded more fat-free mass and IGF-1 but no rise in strength.
What does RAD-140 do to the brain? Neuron and rat studies
What does RAD-140 do to the brain is known only from nerve-cell and rat studies, where it shielded neurons from injury about as well as testosterone did.
RAD 140 study: what the breast-cancer trials found
The first RAD 140 study tested the compound in 22 postmenopausal women with metastatic breast cancer, setting 100 mg daily as the highest tolerated dose.